Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport

RPF Dullaart, Aad Tol

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
1 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)509-513
Number of pages5
JournalDiabetic Medicine
Publication statusPublished - 2001

Cite this